The reliability of lymphoma diagnosis in small tissue samples is heavily influenced by lymphoma subtype

被引:27
作者
Farmer, Patricia L.
Bailey, Denis J.
Burns, Bruce F.
Day, Andrew
LeBrun, David P. [1 ]
机构
[1] Queens Univ, Richardson Lab, Dept Pathol & Lab Med, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada
[4] Kingston Gen Hosp, Clin Res Ctr, Kingston, ON, Canada
关键词
lymphoma; tissue microarray; needle biopsy; immunophenotyping;
D O I
10.1309/J7Y74D9DXEAJ9YUY
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A specific pathologic diagnosis is important in malignant lymphoma because the diverse disease subtypes require tailored approaches to clinical management. Reliance on small samples obtained with cutting needles has been advocated as a less invasive alternative to using larger excised samples. Although published studies have demonstrated the safety and apparent sufficiency of this approach in informing clinical care, none have systematically determined the accuracy of pathologic lymphoma subtyping based on very small samples. We used a tissue microarray representing 67 cases of malignant lymphoma and 17 samples of nonneoplastic lymphoid tissue to model lymphoma diagnosis in small samples. Overall, 73.8% of the cases were diagnosed with a level of confidence deemed sufficient for directing clinical management; 85.9% of these diagnoses were accurate. Small cell lymphomas with highly distinctive immunophenotypes, including small lymphocytic, mantle cell, and T-lymphoblastic lymphoma, were recognized most consistently and accurately in the small samples. In contrast, follicular lymphoma and marginal zone lymphoma were especially difficult. Our results indicate that the reliability of lymphoma diagnoses based on small samples is heavily influenced by lymphoma subtype.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 16 条
[1]   CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: Experience of 267 biopsies [J].
Agid, R ;
Sklair-Levy, M ;
Bloom, AI ;
Lieberman, S ;
Polliack, A ;
Ben-Yehuda, D ;
Sherman, Y ;
Libson, E .
CLINICAL RADIOLOGY, 2003, 58 (02) :143-147
[2]   Efficacy of CT-guided percutaneous needle biopsy in the diagnosis of malignant lymphoma at first presentation [J].
Balestreri, L ;
Morassut, S ;
Bernardi, D ;
Tavio, M ;
Talamini, R ;
Gloghini, A ;
Carbone, A .
CLINICAL IMAGING, 2005, 29 (02) :123-127
[3]  
de Kerviler E, 2000, CANCER, V89, P647, DOI 10.1002/1097-0142(20000801)89:3<647::AID-CNCR21>3.0.CO
[4]  
2-R
[5]   Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas [J].
Demharter, J ;
Müller, P ;
Wagner, T ;
Schlimok, G ;
Haude, K ;
Bohndorf, K .
EUROPEAN RADIOLOGY, 2001, 11 (02) :276-283
[6]  
Fleiss J. L., 1981, Statistical Methods for Rates and Proportions, V2nd
[7]  
Gascoyne Randy D, 2005, Hematology Am Soc Hematol Educ Program, P299
[8]   Computed-tomography-guided percutaneous core needle biopsies of suspected malignant lymphomas:: Impact of biopsy, lesion, and patient parameters on diagnostic yield [J].
Hesselmann, V ;
Zähringer, M ;
Krug, B ;
Wesselmann, C ;
Haferkamp, K ;
Wickenhauser, C ;
Lackner, K .
ACTA RADIOLOGICA, 2004, 45 (06) :641-645
[9]  
Jaffe ES., 2001, PATHOLOGY GENETICS T
[10]   Role of image-guided core-needle biopsy in the management of patients With lymphoma [J].
Pappa, VI ;
Hussain, HK ;
Reznek, RH ;
Whelan, J ;
Norton, AJ ;
Wilson, AM ;
Love, J ;
Lister, TA ;
Rohatiner, AZS .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2427-2430